These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21845176)

  • 1. A novel elevated plus-maze procedure to avoid the one-trial tolerance problem.
    Schneider P; Ho YJ; Spanagel R; Pawlak CR
    Front Behav Neurosci; 2011; 5():43. PubMed ID: 21845176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity.
    Albrechet-Souza L; Borelli KG; Carvalho MC; Brandão ML
    Neuroscience; 2009 Dec; 164(2):387-97. PubMed ID: 19699782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increases in plasma corticosterone and stretched-attend postures in rats naive and previously exposed to the elevated plus-maze are sensitive to the anxiolytic-like effects of midazolam.
    Albrechet-Souza L; Cristina de Carvalho M; Rodrigues Franci C; Brandão ML
    Horm Behav; 2007 Aug; 52(2):267-73. PubMed ID: 17553501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze.
    Bertoglio LJ; Carobrez AP
    Pharmacol Biochem Behav; 2002 May; 72(1-2):449-55. PubMed ID: 11900819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats.
    Bertoglio LJ; Carobrez AP
    Psychopharmacology (Berl); 2003 Dec; 170(4):335-42. PubMed ID: 13680083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMDA and D1 receptors are involved in one-trial tolerance to the anxiolytic-like effects of diazepam in the elevated plus maze test in rats.
    Zhou H; Yu CL; Wang LP; Yang YX; Mao RR; Zhou QX; Xu L
    Pharmacol Biochem Behav; 2015 Aug; 135():40-5. PubMed ID: 26004015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure.
    Frussa-Filho R; Ribeiro Rde A
    Life Sci; 2002 Jun; 71(5):519-25. PubMed ID: 12052436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of learning of open arm avoidance in the phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in mice.
    Calzavara MB; Patti CL; Lopez GB; Abílio VC; Silva RH; Frussa-Filho R
    Life Sci; 2005 Mar; 76(19):2235-46. PubMed ID: 15733938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the mineralocorticoid receptors in the medial prefrontal cortex prevents the acquisition of one-trial tolerance in mice.
    Albernaz-Mariano KA; Souza RR; Canto-de-Souza A
    Behav Brain Res; 2022 Aug; 431():113938. PubMed ID: 35618080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. U-69,593 microinjection in the infralimbic cortex reduces anxiety and enhances spontaneous alternation memory in mice.
    Wall PM; Messier C
    Brain Res; 2000 Feb; 856(1-2):259-80. PubMed ID: 10677636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced dorsolateral periaqueductal gray activity counteracts the anxiolytic response to midazolam on the elevated plus-maze Trial 2 in rats.
    Bertoglio LJ; Anzini C; Lino-de-Oliveira C; Carobrez AP
    Behav Brain Res; 2005 Jul; 162(1):99-107. PubMed ID: 15922070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of fear-induced antinociception with intra-amygdala infusion of midazolam: Influence of prior test experience.
    Baptista D; Bussadori K; Nunes-de-Souza RL; Canto-de-Souza A
    Brain Res; 2009 Oct; 1294():29-37. PubMed ID: 19635465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.
    Barbalho CA; Nunes-de-Souza RL; Canto-de-Souza A
    Brain Res; 2009 Apr; 1267():65-76. PubMed ID: 19268657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scopolamine given pre-Trial 1 prevents the one-trial tolerance phenomenon in the elevated plus-maze Trial 2.
    Bertoglio LJ; Carobrez AP
    Behav Pharmacol; 2004 Feb; 15(1):45-54. PubMed ID: 15075626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J; Nunes-de-Souza RL
    Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze.
    Bessa JM; Oliveira M; Cerqueira JJ; Almeida OF; Sousa N
    Behav Brain Res; 2005 Jul; 162(1):135-42. PubMed ID: 15922074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1.
    Dal-Cól ML; Pereira LO; Rosa VP; Calixto AV; Carobrez AP; Faria MS
    Pharmacol Biochem Behav; 2003 Jan; 74(2):395-400. PubMed ID: 12479960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat.
    Cruz-Morales SE; Santos NR; Brandão ML
    Pharmacol Biochem Behav; 2002 Jul; 72(4):973-8. PubMed ID: 12062588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.